Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.616
+0.025 (4.21%)
At close: Dec 5, 2025, 4:00 PM EST
0.610
-0.006 (-1.01%)
After-hours: Dec 5, 2025, 7:58 PM EST
RVPH Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 8.27 | 7.89 | 8.08 | 5.36 | 5.25 | 2.14 | |
| Research & Development | 14.65 | 22.91 | 31.42 | 22.87 | 4.85 | 0.3 | |
| Operating Expenses | 22.93 | 30.8 | 39.5 | 28.23 | 10.1 | 2.43 | |
| Operating Income | -22.93 | -30.8 | -39.5 | -28.23 | -10.1 | -2.43 | |
| Interest Expense | -0.02 | -0.02 | -0.03 | - | -0 | -1.45 | |
| Interest & Investment Income | 0.22 | 0.36 | 0.4 | 0.18 | - | 0.08 | |
| Other Non Operating Income (Expenses) | -0 | 0.56 | -0.1 | -0.19 | 1.59 | 0.03 | |
| Pretax Income | -22.74 | -29.9 | -39.24 | -28.24 | -8.52 | -3.78 | |
| Income Tax Expense | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0 | |
| Net Income | -22.76 | -29.92 | -39.26 | -28.26 | -8.52 | -3.78 | |
| Net Income to Common | -22.76 | -29.92 | -39.26 | -28.26 | -8.52 | -3.78 | |
| Shares Outstanding (Basic) | 52 | 33 | 24 | 20 | 15 | 3 | |
| Shares Outstanding (Diluted) | 52 | 33 | 24 | 20 | 15 | 3 | |
| Shares Change (YoY) | 72.64% | 39.28% | 21.94% | 31.95% | 383.10% | 10.60% | |
| EPS (Basic) | -0.43 | -0.90 | -1.65 | -1.45 | -0.58 | -1.24 | |
| EPS (Diluted) | -0.43 | -0.90 | -1.65 | -1.45 | -0.58 | -1.24 | |
| EBITDA | - | - | - | - | -10.1 | -2.43 | |
| D&A For EBITDA | - | - | - | - | 0 | 0 | |
| EBIT | -22.93 | -30.8 | -39.5 | -28.23 | -10.1 | -2.43 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.